Halozyme Therapeutics HALO

$ 45.45 -0.69%

Quarterly report 2024-Q3
added 10-31-2024

Halozyme Therapeutics EV/EBITDA Ratio 2011-2024 | HALO

Annual EV/EBITDA Ratio Halozyme Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
17.2	48	-48.6	-35.3	31.9	-19.6	-43.5	-28.4	-23	-13.7	-55.4

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48	-55.4	-15.5